^
Association details:
Biomarker:No biomarker
Cancer:Thyroid Gland Papillary Carcinoma
Drug:Prolia (denosumab) (RANK ligand inhibitor)
Direction:Sensitive
Evidence:
Evidence Level:
Sensitive: A2 - Guideline
New
Source:
Excerpt:
Papillary Thyroid Cancer: Bone metastases…Consider intravenous bisphosphonate or denosumab